Boston Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.82M Buy
103,156
+8,428
+9% +$171K 0.1% 265
2019
Q2
$2.02M Sell
94,728
-17,540
-16% -$368K 0.11% 216
2019
Q1
$2.67M Buy
112,268
+58,114
+107% +$1.33M 0.14% 192
2018
Q4
$1.06M Buy
+54,154
New +$965K 0.06% 301

Other funds holding EXEL

Boston Advisors's EXEL Position: Q3 2019 in Review

Boston Advisors increased its Exelixis (EXEL) stake by 8.9% in Q3 2019, buying an estimated $171K and bringing the position to 103,156 shares worth $1.82M. The position accounts for 0.1% of the portfolio, ranked #265.

Boston Advisors first reported a position in EXEL in Q4 2018 and has held it in 4 quarters since. The position peaked at $2.67M in Q1 2019. 339 funds tracked by Wall St. Rank hold EXEL as of Q3 2019.

  • Boston Advisors held 103,156 shares of Exelixis worth $1.82M as of Q3 2019.
  • Boston Advisors bought 8,428 Exelixis shares in Q3 2019, an estimated $171K.
  • Exelixis made up 0.1% of Boston Advisors's portfolio in Q3 2019, its #265 holding.
  • Boston Advisors first reported a position in Exelixis in Q4 2018 and has held it in 4 quarters since.
  • Boston Advisors's Exelixis position peaked at $2.67M in Q1 2019.
  • 339 funds tracked by Wall St. Rank held Exelixis as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.